1. |
Prasterone: caution over ‘superhormone’ claims |
|
Inpharma Weekly,
Volume &NA;,
Issue 1063,
1996,
Page 2-2
&NA;,
Preview
|
PDF (1125KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
2. |
Will estrogen be a key player in future cardioprotection? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1063,
1996,
Page 3-5
Gill Higgins,
Preview
|
PDF (3406KB)
|
|
摘要:
Future research may see scientists developing synthetic estrogen analogues that have the cardioprotective action of endogenous estrogen, but a reduced potential for estrogen-associated adverse effects. Such therapy could prove beneficial in both men and women. At present, the race is on to determine exactly how estrogen exerts its protective effect. The latest findings in this field were presented at the 69th Scientific Sessions of the American Heart Association (AHA) [New Orleans, US; November 1996]. Other findings relating to cardiovascular differences between men and women, such as the effects of aggressive lipid-lowering therapy, were also reported at the conference.
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
3. |
Adjunctive medication for elderly patients with depression |
|
Inpharma Weekly,
Volume &NA;,
Issue 1063,
1996,
Page 5-5
&NA;,
Preview
|
PDF (1115KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
4. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1063,
1996,
Page 6-6
&NA;,
Preview
|
PDF (1054KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
5. |
Intensive insulin therapy cost effective, says DCCT group |
|
Inpharma Weekly,
Volume &NA;,
Issue 1063,
1996,
Page 7-7
&NA;,
Preview
|
PDF (1064KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
6. |
Increase in platelet count with PEG-thrombopoietin |
|
Inpharma Weekly,
Volume &NA;,
Issue 1063,
1996,
Page 8-8
&NA;,
Preview
|
PDF (1058KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
7. |
New developments in the treatment of hepatitis & rotavirus infections |
|
Inpharma Weekly,
Volume &NA;,
Issue 1063,
1996,
Page 9-10
Gill Higgins,
Preview
|
PDF (2159KB)
|
|
摘要:
A vaccine that protects against rotavirus infection and a new target for developing drugs against hepatitis C were among the significant developments in antiviral therapy that were reported at the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy [New Orleans, US; September 1996]. The RRV-TV vaccine looks set to be the world's first licensed vaccine for the prevention of rotavirus-associated gastroenteritis, and the results of a study reported at the conference indicated that it provides complete protection against severe disease. Regarding hepatitis, the discovery of the protease enzyme of hepatitis C virus (HCV), and the development of new nucleoside analogues against hepatitis B virus (HBV), could herald a long-awaited new era in the treatment of hepatitis infections.
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
8. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1063,
1996,
Page 10-10
&NA;,
Preview
|
PDF (1082KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
9. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1063,
1996,
Page 11-11
&NA;,
Preview
|
PDF (1010KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
10. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1063,
1996,
Page 12-12
&NA;,
Preview
|
PDF (1049KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|